WorksheetsRespiratory Diseases Tutorial Quiz
Total questions: 12
Worksheet time: 6mins
Which of the following is an example of an obstructive pulmonary disease?
Asthma
Tuberculosis
Lung cancer
Influenza
In the context of lung function tests, what does FEV1 stand for?
Forced Expiratory Volume in 1 second
Final Exhaled Volume in 1 minute
First Expiratory Value in 1 second
Forced Expiratory Value in 10 seconds
Which of the following best describes FVC as shown in the diagram?
The total volume of air exhaled after a full inhalation
The volume of air inhaled in one second
The amount of oxygen absorbed by the blood
The pressure in the lungs during exhalation
A patient has a reduced FEV1/FVC ratio. Based on your information, what is the most likely clinical implication?
The patient may have early-stage COPD
The patient has high blood sugar
The patient is experiencing acute kidney failure
The patient has a broken rib
A patient has a normal FEV1/FVC ratio but a declining FEF 25-75%. What might this indicate?
Early signs of small airway disease
Normal lung function
Heart disease
Liver dysfunction
If a patient has an FEV1/FVC ratio of 60%, which condition is most likely present?
COPD
Normal lung function
Lung Cancer
Pulmonary fibrosis
Given FEV1 = 4L and FVC = 5L, calculate the FEV1/FVC ratio and determine if it is normal.
80%, Normal
60%, Abnormal
50%, Abnormal
100%, Normal
Based on the clinical presentation, what can be inferred about the effectiveness of combined LAMA and LABA therapy compared to LAMA alone?
Combined therapy was more effective in reducing symptoms and exacerbations.
LAMA alone was more effective.
Both therapies were equally effective.
Neither therapy had any effect.
Why might elevated levels of blood biomarkers be clinically significant in COPD patients?
They can indicate more severe disease and help monitor progression and therapy response.
They always indicate a bacterial infection.
They are only used to diagnose diabetes.
They are unrelated to disease severity.
Which pharmacological treatment is recommended for Group A patients with low symptoms and low exacerbations?
Short-acting bronchodilators
Long-acting bronchodilators (LAMA or LABA)
LAMA
LAMA or LAMA + LABA
What is the primary benefit of using a combination of LAMA and LABA in COPD management?
Increased risk of exacerbations.
Lower cost compared to single therapies.
Improved lung function and reduced symptoms.
Fewer side effects than using LAMA alone.
What does a decrease in FEF 25-75% suggest about a patient's lung function?
Possible small airway obstruction.
Normal lung function.
Increased lung capacity.
Severe restrictive lung disease.
